Tackling Key Concerns in Atopic Dermatitis + Biologic Use

Casey Butrus, PharmD; Michael Cameron, MD, FAAD, and Brittany Craiglow, MD, address the critical clinical challenges in treating atopic dermatitis (AD) patients and discuss current trends in biologics use for AD.

  1. As it relates to the current treatment landscape for atopic dermatitis, what are the most pressing clinical concerns in treating patients with this disease?

  1. What trends are you seeing related to the use of biologics and injectables in the management of AD, and what are the cost implications of these trends?
Related Videos
timothy caulfield, JD
dr ibrahim aldoss
dr anna sureda
Related Content
CH LogoCenter for Biosimilars Logo